Botulinum Treatment
The Botulinum Toxin (Botox) Treatment Clinic at the University of Kentucky began in 1989. As the state's oldest and largest Botulinum Treatment Clinic, University of Kentucky Neurologists have extensive experience treating pediatric and adult patients for a wide range of medical conditions with botulinum toxin, in particular spasmotic torticollis (cervical dystonia). This therapeutic modality has been employed for blepharospasm, spastic dysphonia, limb dystonias, "writer's cramp", achalasia, voice (in concert with ENT) and spastic disorders. Often Electromyographic guidance is employed to localize the target muscle.
In 2010, FDA approved the use of OnabotulinumtoxinA (Botox) in patients suffering from chronic frequent disabling migraines, defined as more than 15 headache days in a month. Research suggests that Botox may be useful in reducing the number of headache days in these patients. Many headache experts at KNI evaluate patients with complex and challenging headaches and utilize Botox when appropriate as part of a comprehensive treatment plan for headaches.
Botulinum Treatment Attending Faculty
Michael R. Dobbs, MD
|
Julie Gurwell, PhD, PA-C
|
Siddharth Kapoor, MD, FAHS
|
Kevin R. Nelson, MD
|
Stephen J. Ryan, MD
|
